|
Reviews
Lipoprotein metabolism in diabetes mellitus
BV Howard
You have reached the most complete version of this article accessible without further authentication.
More complete versions are available.
Link to article
|
Article topics:
- Medicine..Lipoproteins
- Medicine..Lipases
- Medicine..Diabetes Mellitus
- Biochemistry..Low-Density Lipoproteins
- Physiology..Humans
- Biochemistry..Lipoprotein Metabolism
- Medicine..Non-Insulin-Dependent Diabetes Mellitus
- Biophysics..Metabolism
- Medicine..Cholesterol
- Medicine..Diabetes

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Qin, R. A. Anderson, and K. Adeli
Tumor necrosis factor-{alpha} directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling
Am J Physiol Gastrointest Liver Physiol,
May 1, 2008;
294(5):
G1120 - G1129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Albers, S. M. Marcovina, G. Imperatore, B. M. Snively, J. Stafford, W. Y. Fujimoto, E. J. Mayer-Davis, D. B. Petitti, C. Pihoker, L. Dolan, et al.
Prevalence and Determinants of Elevated Apolipoprotein B and Dense Low-Density Lipoprotein in Youths with Type 1 and Type 2 Diabetes
J. Clin. Endocrinol. Metab.,
March 1, 2008;
93(3):
735 - 742.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. N Bavenholm and S. Efendic
Postprandial hyperglycaemia and vascular damage - the benefits of acarbose
Diabetes and Vascular Disease Research,
September 1, 2006;
3(2):
72 - 79.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H. N. Ginsberg
REVIEW: Efficacy and Mechanisms of Action of Statins in the Treatment of Diabetic Dyslipidemia
J. Clin. Endocrinol. Metab.,
February 1, 2006;
91(2):
383 - 392.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Woerle, E. Szoke, C. Meyer, J. M. Dostou, S. D. Wittlin, N. R. Gosmanov, S. L. Welle, and J. E. Gerich
Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes
Am J Physiol Endocrinol Metab,
January 1, 2006;
290(1):
E67 - E77.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Myerson, C. Ngai, J. Jones, S. Holleran, R. Ramakrishnan, L. Berglund, and H. N. Ginsberg
Treatment with high-dose simvastatin reduces secretion of apolipoprotein B-lipoproteins in patients with diabetic dyslipidemia
J. Lipid Res.,
December 1, 2005;
46(12):
2735 - 2744.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Iwasaki, S. Takahashi, M. Takahashi, Y. Zenimaru, T. Kujiraoka, M. Ishihara, M. Nagano, J. Suzuki, I. Miyamori, H. Naiki, et al.
Deficiency of the Very Low-Density Lipoprotein (VLDL) Receptors in Streptozotocin-Induced Diabetic Rats: Insulin Dependency of the VLDL Receptor
Endocrinology,
August 1, 2005;
146(8):
3286 - 3294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. W. Lau, M. Journoud, and P. J. Jones
Plant sterols are efficacious in lowering plasma LDL and non-HDL cholesterol in hypercholesterolemic type 2 diabetic and nondiabetic persons
Am. J. Clinical Nutrition,
June 1, 2005;
81(6):
1351 - 1358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Brehm, G. Pfeiler, G. Pacini, H. Vierhapper, and M. Roden
Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Obesity
Clin. Chem.,
December 1, 2004;
50(12):
2316 - 2322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Pruneta-Deloche, A. Sassolas, G. M. Dallinga-Thie, F. Berthezene, G. Ponsin, and P. Moulin
Alteration in lipoprotein lipase activity bound to triglyceride-rich lipoproteins in the postprandial state in type 2 diabetes
J. Lipid Res.,
May 1, 2004;
45(5):
859 - 865.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ouguerram, T. Magot, Y. Zair, J. S. Marchini, B. Charbonnel, H. Laouenan, and M. Krempf
Effect of Atorvastatin on Apolipoprotein B100 Containing Lipoprotein Metabolism in Type-2 Diabetes
J. Pharmacol. Exp. Ther.,
July 1, 2003;
306(1):
332 - 337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Valabhji and R. S Elkeles
Dyslipidaemia in type 2 diabetes: epidemiology and biochemistry
The British Journal of Diabetes & Vascular Disease,
May 1, 2003;
3(3):
184 - 189.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Duvillard, E. Florentin, G. Lizard, J.-M. Petit, F. Galland, S. Monier, P. Gambert, and B. Verges
Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy
Diabetes Care,
May 1, 2003;
26(5):
1540 - 1544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-H. Lee, M. A. Magnuson, V. Muppala, and S.-S. Chen
Liver-Specific Reactivation of the Inactivated Hnf-1{alpha} Gene: Elimination of Liver Dysfunction To Establish a Mouse MODY3 Model
Mol. Cell. Biol.,
February 1, 2003;
23(3):
923 - 932.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Georgopoulos, O. Aras, M. Noutsou, and M. Y. Tsai
Unlike Type 2 Diabetes, Type 1 Does Not Interact with the Codon 54 Polymorphism of the Fatty Acid Binding Protein 2 Gene
J. Clin. Endocrinol. Metab.,
August 1, 2002;
87(8):
3735 - 3739.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Sniderman, T. Scantlebury, and K. Cianflone
Hypertriglyceridemic HyperapoB: The Unappreciated Atherogenic Dyslipoproteinemia in Type 2 Diabetes Mellitus
Ann Intern Med,
September 18, 2001;
135(6):
447 - 459.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. L. Wajchenberg
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
Endocr. Rev.,
December 1, 2000;
21(6):
697 - 738.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Frikke-Schmidt, B. G. Nordestgaard, B. Agerholm-Larsen, P. Schnohr, and A. Tybjærg-Hansen
Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype
J. Lipid Res.,
November 1, 2000;
41(11):
1812 - 1822.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Georgopoulos, J. P. Bantle, M. Noutsou, and H. A. Hoover
A High Carbohydrate versus a High Monounsaturated Fatty Acid Diet Lowers the Atherogenic Potential of Big VLDL Particles in Patients with Type 1 Diabetes
J. Nutr.,
October 1, 2000;
130(10):
2503 - 2507.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Simonen, H. Gylling, A. N Howard, and T. A Miettinen
Introducing a new component of the metabolic syndrome: low cholesterol absorption
Am. J. Clinical Nutrition,
July 1, 2000;
72(1):
82 - 88.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Taghibiglou, A. Carpentier, S. C. Van Iderstine, B. Chen, D. Rudy, A. Aiton, G. F. Lewis, and K. Adeli
Mechanisms of Hepatic Very Low Density Lipoprotein Overproduction in Insulin Resistance. EVIDENCE FOR ENHANCED LIPOPROTEIN ASSEMBLY, REDUCED INTRACELLULAR ApoB DEGRADATION, AND INCREASED MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN IN A FRUCTOSE-FED HAMSTER MODEL
J. Biol. Chem.,
March 17, 2000;
275(12):
8416 - 8425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Knobler, A. Schattner, T. Zhornicki, S.D.H. Malnick, D. Keter, N. Sokolovskaya, Y. Lurie, and D.D. Bass
Fatty liver—an additional and treatable feature of the insulin resistance syndrome
QJM,
February 1, 1999;
92(2):
73 - 79.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M D FEHER and R S ELKELES
Lipid modification and coronary heart disease in type 2 diabetes: different from the general population?
Heart,
January 1, 1999;
81(1):
10 - 11.
[Full Text]
|
 |
|

|
 |

|
 |
 
L. S. Sidossis, B. Mittendorfer, E. Walser, D. Chinkes, and R. R. Wolfe
Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion
Am J Physiol Endocrinol Metab,
November 1, 1998;
275(5):
E798 - E805.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Aarsland and R. R. Wolfe
Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men
J. Lipid Res.,
June 1, 1998;
39(6):
1280 - 1286.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Georgopoulos, J. P. Bantle, M. Noutsou, W. R. Swaim, and S. J. Parker
Differences in the Metabolism of Postprandial Lipoproteins After a High-Monounsaturated-Fat Versus a High-Carbohydrate Diet in Patients With Type 1 Diabetes Mellitus
Arterioscler. Thromb. Vasc. Biol.,
May 1, 1998;
18(5):
773 - 782.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. R. Fisher, L. A. Zech, and P. W. Stacpoole
Apolipoprotein B metabolism in hypertriglyceridemic diabetic patients administered either a fish oil- or vegetable oil-enriched diet
J. Lipid Res.,
February 1, 1998;
39(2):
388 - 401.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Bressler and D. G. Johnson
Pharmacological Regulation of Blood Glucose Levels in Non--Insulin-Department Diabetes Mellitus
Arch Intern Med,
April 28, 1997;
157(8):
836 - 848.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Coussons, C. S. Bourgeois, D. Wiggins, and G. F. Gibbons
Selective Recruitment of ApoB-48 for the Assembly of VLDL in Rat Triacylglycerol-Enriched Hepatocytes
Arterioscler. Thromb. Vasc. Biol.,
July 1, 1996;
16(7):
889 - 897.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. T.K. Singh, D. L. Rainwater, S. M. Haffner, J. L. VandeBerg, W. R. Shelledy, P. H. Moore Jr, and T. D. Dyer
Effect of Diabetes on Lipoprotein Size
Arterioscler. Thromb. Vasc. Biol.,
November 1, 1995;
15(11):
1805 - 1811.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. E. Tan, L. Forster, M. J. Caslake, D. Bedford, T. D. G. Watson, M. McConnell, C. J. Packard, and J. Shepherd
Relations Between Plasma Lipids and Postheparin Plasma Lipases and VLDL and LDL Subfraction Patterns in Normolipemic Men and Women
Arterioscler. Thromb. Vasc. Biol.,
November 1, 1995;
15(11):
1839 - 1848.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Delcker, H.C. Diener, and H. Wilhelm
Influence of Vascular Risk Factors for Atherosclerotic Carotid Artery Plaque Progression
Stroke,
November 1, 1995;
26(11):
2016 - 2022.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Syvanne, J. Kahri, K. S. Virtanen, and M.-R. Taskinen
HDLs Containing Apolipoproteins A-I and A-II (LpA-I:A-II) as Markers of Coronary Artery Disease in Men With Non–Insulin- Dependent Diabetes Mellitus
Circulation,
August 1, 1995;
92(3):
364 - 370.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. E. Reiber, R. E. Pecoraro, and T. D. Koepsell
Risk Factors for Amputation in Patients with Diabetes Mellitus: A Case-Control Study
Ann Intern Med,
July 15, 1992;
117(2):
97 - 105.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Ramirez, C. Arauz-Pacheco, C. Lackner, G. Albright, B. V. Adams, and P. Raskin
Lipoprotein (a) Levels in Diabetes Mellitus: Relationship to Metabolic Control
Ann Intern Med,
July 1, 1992;
117(1):
42 - 47.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Henkin, J. A. Como, and A. Oberman
Secondary Dyslipidemia: Inadvertent Effects of Drugs in Clinical Practice
JAMA,
February 19, 1992;
267(7):
961 - 968.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Saudek
When Does Diabetes Start?
JAMA,
June 6, 1990;
263(21):
2934 - 2934.
[Abstract]
[PDF]
|
 |
|
|